VanHimbergen Robert M 4

What Happened

• Robert M. VanHimbergen, EVP and Chief Financial Officer of Elanco Animal Health Inc. (ELAN), received a grant of 8.151 deferred stock units (DSUs) on June 12, 2026. The grant is reported at a per-unit value of $24.17, totaling approximately $197. This is an award (A) — part of compensation — not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-12; Form 4 filed: 2026-06-16 (filed on time).
• Reported amount: 8.151 DSUs at $24.17 per unit; aggregate reported value ≈ $197.
• Transaction type/code: A = Award/Grant (derivative units).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: F1 — each DSU represents the right to one share of common stock or cash equivalent. F2 — DSUs settle in cash or shares after termination of employment or in a specified future year under the company’s Executive Deferral and Stock Match Plan.

Context

• Deferred stock units are a form of deferred compensation; they do not transfer actual shares immediately and typically convert to cash or stock at a later date, so they are routine compensation rather than a direct bullish or bearish insider trading signal.